Pharmacogenetic Tests: US FDA Tries Off-Label Approach To Guide Consumers

 
• By Michael McCaughan
  
open plastic vinyl window on house background
The US FDA's new pharmacogenomics table has opened the door ever so slightly on off-label test data.

More from US FDA

More from Agency Leadership